how are compounding pharmacies still making tirzepatide FDA Says Can Keep Med The Tirzepatide Shortage Is Over:

Monitor for localized metabolic dullness, nausea, or altered gastric emptying, which are common secondary responses during the maintenance phase

Your healthcare provider can order labs at the 8-week mark to assess early progress and adjust your dose if needed to optimize your A1C trajectory

Discontinuing it may slow progress, which is why Ambra provides ongoing support and maintenance planning to help you stay consistent

In studies of tirzepatide in people without diabetes, average weight loss was higher about 21% with the highest dose

Some patients benefit from weekly injections, while others may only need one once a month